Tocilizumab by F. Hoffmann-La Roche for Non-Small Cell Lung Cancer: Likelihood of Approval

Retrieved on: 2024-09-09 19:37:26

Tags for this article:

Click the tags to see associated articles and topics

Tocilizumab by F. Hoffmann-La Roche for Non-Small Cell Lung Cancer: Likelihood of Approval. View article details on hiswai:

Excerpt

Tocilizumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Non-Small Cell Lung Cancer.

Article found on: www.pharmaceutical-technology.com